Vitrotest Bioreagent LLC
Vitrotest Bioreagent LLC company was established in Kyiv in 2018 as a result of the reorganization of NPK Vitrotest Ltd. (was founded in 2006) with the acquisition of new investments. It produces ELISA test-kits for the diagnostics of infectious human diseases, and in March 2020 began producing test-kits for the diagnostics of COVID-19.
Vitrotest Europe Sp. z o.o.
In 2020, a team of scientists together with partners from the "Kvarko" fund established the company Vitrotest Europe Sp. z o.o., to promote the production of ELISA kits. In the same year, the company received a grant from the European Union and the National Center for Research and Development for the implementation of a project entitled "Development of new type of synthetic controls in ELISA diagnostic tests on the example of a measles virus infection detection test". Thanks to the grant, we started the production of immunoenzymatic kits in Poland.
In addition, the company represents the Ukrainian producer of immunoenzymatic kits Vitrotest Bioreagent LLC in the European Union.